Marta
Llanos Muñoz
Part Time Assistant Professor (Health Science)


Instituto de Salud Carlos III
Madrid, EspañaPublications in collaboration with researchers from Instituto de Salud Carlos III (3)
2018
-
First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183